Argus Research Maintains Buy on Salesforce, Raises Price Target to $300

Benzinga Newsdesk www.benzinga.com Neutral 54.3%

Neg 0% Neu 54.3% Pos 0%

Argus Research analyst Joseph Bonner maintains Salesforce (NYSE:CRM) with a Buy and raises the price target from $290 to $300.